Docetaxel Injection USP recall in Canada: Product safety
In plain language
This recall involves Docetaxel Injection USP 10 mg/mL sold in Canada. It's being recalled because an impurity, 10-oxo-docetaxel, could be out-of-specification. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number DC31807A.
- Contact Pfizer Canada ULC for instructions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Docetaxel Injection USP 10 mg/mL
Lot: DC31807A
Why this matters
Product safety issue due to impurity
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: DC31807A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product safety issue due to impurity
What should consumers do?
Stop using the product immediately. Check the lot number DC31807A. Contact Pfizer Canada ULC for instructions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product safety issue due to impurity
When was this product recalled?
This product was recalled on October 4, 2019.